
Journal of Medicinal Chemistry p. 1618 - 1623 (1992)
Update date:2022-09-26
Topics:
Nihro, Yasunori
Sogawa, Satoshi
Izumi, Akihiro
Sasamori, Akihiro
Sudo, Tadamitsu
et al.
Structural modification of ascorbic acid by substitution of the 3-hydroxy group with lipophilic moieties has allowed the development of agents for treating reperfusion injury.These ascorbic acid derivatives inhibited lipid peroxidation, and some of them also reduced coronary reperfusion-induced arrhythmias in anesthetized rats.We found that 3-O-<(dodecylcarbonyl)methyl>ascorbic acid (8) was protective against reperfusion injury without directly influencing hemodynamics. 2-O-Octadecylascorbic acid (19) and 5,6-O-dodecylideneascorbic acid (15) also exhibited a marked effect on reperfusion injury, but significantly reduced the arterial blood pressure and heart rate in rats.
View Morewuxi huabin bio-tech Co.,Ltd(expird)
Contact:86-0510-85133006
Address:hubin road NO157
puyang hongda shengdao new material co.,ltd.
Contact:+86-393- 4896278
Address:No.29 East Zhongyuan Road
China Synchem Technology Co.,Ltd
website:http://www.cnsynchem.com
Contact:+86-0552-4929311
Address:No.217 Daqing Road
Chengdu King-tiger Pharm-chem. Tech. Co., Ltd
Contact:028-85317716
Address:Tianfu Life Science Park, No. 88 South Keyuan Road, Gaoxin District, Chengdu City, Sichuan Province, PRC.
Beijing Harmony Chemical Co., Ltd.
Contact:86-010-84956928
Address:Room 207, Jin feng he B building, No 8 Xin Jie Kou Wai Street, Xi Cheng District, Beijing,PRC. 10008
Doi:10.1007/BF00960350
()Doi:10.1016/S0040-4020(01)85436-3
(1990)Doi:10.1142/S1088424610002938
(2010)Doi:10.1002/chem.201900951
(2019)Doi:10.1021/ol2005159
(2011)Doi:10.1248/cpb.44.515
(1996)